Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Kodiak Sciences Inc. (KOD)

63.97   6.38 (11.08%) 02-28 16:00
Open: Pre. Close: 57.59
High: 64.48 Low: 55.32
Volume: 554,077 Market Cap: 2812M
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase I clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidates include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases; KSI-201, a recombinant mammalian cell expressed dual inhibitor antibody biopolymer bioconjugate for the treatment of wet AMD; and KSI-401, a recombinant mammalian cell expressed antibody biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 64.54 - 64.853 64.853 - 65.123
Low: 54.663 - 54.98 54.98 - 55.254
Close: 63.428 - 63.989 63.989 - 64.473

Technical analysis

as of: 2020-02-28 4:30:06 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 84.29     One year: 96.65
Support: Support1: 55.05    Support2: 45.80
Resistance: Resistance1: 72.17    Resistance2: 82.75
Pivot: 62.20
Moving Average: MA(5): 60.47     MA(20): 62.92
MA(100): 48.37     MA(250): 25.68
MACD: MACD(12,26): -1.08     Signal(9): -0.90
Stochastic oscillator: %K(14,3): 22.62     %D(3): 18.80
RSI: RSI(14): 52.24
52-week: High: 82.75  Low: 5.86  Change(%): 815.2
Average Vol(K): 3-Month: 62003  10-Days: 43907

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
KOD has closed below upper band by 40.5%. Bollinger Bands are 5.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 10 Feb 2020 21:00:22 +0000
Health Care Sector Update for 02/10/2020: NTLA,KOD,VTVT,ZLAB

Mon, 10 Feb 2020 19:16:12 +0000
Health Care Sector Update for 02/10/2020: KOD,VTVT,ZLAB

Fri, 07 Feb 2020 21:26:00 +0000
Notable Friday Option Activity: ZGNX, BYND, KOD

Thu, 06 Feb 2020 20:53:31 +0000
Health Care Sector Update for 02/06/2020: PBH,CAH,KOD,TNXP

Thu, 06 Feb 2020 18:33:16 +0000
Health Care Sector Update for 02/06/2020: CAH,KOD,TNXP

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 43.96
Shares Float (M) 17.33
% Held by Insiders 20.88
% Held by Institutions 69.62
Shares Short (K) 2200
Shares Short P. Month (K)

Stock Financials

EPS -1.250
Book Value (p.s.) 1.610
PEG Ratio -4.22
Profit Margin
Operating Margin
Return on Assets (ttm) -61.5
Return on Equity (ttm) -444.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.952
Qtrly Earnings Growth
Operating Cash Flow (M) -36.19
Levered Free Cash Flow (M) -19.83

Stock Valuations

P/E -51.18
P/E Growth Ratio 0.11
P/BV 39.73
P/CF -77.70

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.